Aura Biosciences Shares up 8% Premarket After Results From Mid-Stage Study of Cancer Treatment
Aura Biosciences股價在盤前上漲8%,在癌症治療中期研究結果發佈後。
Aura Biosciences Shares up 8% Premarket After Results From Mid-Stage Study of Cancer Treatment
Aura Biosciences股價在盤前上漲8%,在癌症治療中期研究結果發佈後。
譯文內容由第三人軟體翻譯。